Prospective cohort study to monitor the emergence of SARSCoV-2 spike viral variants in immunocompromised nonhospitalised patients exposed to sotrovimab in Great Britain: LUNAR study (218407) First published 29/03/2022 Last updated 11/07/2024 EU PAS number:EUPAS46386 Study Finalised